GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-9-5p
|
MIMAT0000441 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_120170052 | 27.50 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr7_-_45960850 | 26.01 |
ENST00000381083.4
ENST00000381086.5 ENST00000275521.6 |
IGFBP3
|
insulin-like growth factor binding protein 3 |
chr5_+_135364584 | 25.65 |
ENST00000442011.2
ENST00000305126.8 |
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr13_+_110959598 | 22.62 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr15_-_60690163 | 19.85 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr3_+_197476621 | 19.39 |
ENST00000241502.4
|
FYTTD1
|
forty-two-three domain containing 1 |
chr4_-_157892498 | 18.34 |
ENST00000502773.1
|
PDGFC
|
platelet derived growth factor C |
chr2_+_203499901 | 18.33 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
chr2_-_161350305 | 18.20 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr15_-_48937982 | 17.85 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
chr2_-_1748214 | 17.75 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr12_-_10875831 | 16.53 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
chr3_+_171758344 | 15.07 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr3_-_185542817 | 14.21 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr8_+_22224811 | 13.96 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr5_+_82767284 | 13.85 |
ENST00000265077.3
|
VCAN
|
versican |
chr5_+_34656331 | 13.71 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
chr21_+_46825032 | 13.10 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
chr5_-_131563501 | 12.99 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr6_-_82462425 | 12.77 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr6_+_116601265 | 12.57 |
ENST00000452085.3
|
DSE
|
dermatan sulfate epimerase |
chr5_-_127873659 | 12.54 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr21_-_44846999 | 12.40 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr1_-_154943212 | 12.33 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr3_-_32544900 | 11.54 |
ENST00000205636.3
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6 |
chr3_+_30648066 | 11.49 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr9_-_117880477 | 11.15 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr2_-_218808771 | 11.10 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
chr10_-_33623564 | 10.26 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
chr10_+_75757863 | 10.18 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
chr3_-_123603137 | 10.17 |
ENST00000360304.3
ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK
|
myosin light chain kinase |
chr5_-_149535421 | 10.11 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr2_+_36582857 | 10.00 |
ENST00000280527.2
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
chr2_+_46524537 | 9.53 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr19_+_797392 | 9.32 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr2_+_235860616 | 9.21 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
chr9_+_101705893 | 9.04 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr22_-_36784035 | 8.83 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr15_-_101792137 | 8.49 |
ENST00000254190.3
|
CHSY1
|
chondroitin sulfate synthase 1 |
chrX_-_109561294 | 8.36 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr8_-_71519889 | 8.17 |
ENST00000521425.1
|
TRAM1
|
translocation associated membrane protein 1 |
chr16_-_65155833 | 7.85 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr1_+_25071848 | 7.82 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
chr13_+_73632897 | 7.78 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr5_+_149340282 | 7.71 |
ENST00000286298.4
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2 |
chr8_-_119124045 | 7.64 |
ENST00000378204.2
|
EXT1
|
exostosin glycosyltransferase 1 |
chr5_+_40909354 | 7.39 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr7_+_115850547 | 7.31 |
ENST00000358204.4
ENST00000455989.1 ENST00000537767.1 |
TES
|
testis derived transcript (3 LIM domains) |
chr1_-_120612240 | 7.29 |
ENST00000256646.2
|
NOTCH2
|
notch 2 |
chr6_+_160390102 | 7.26 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr2_+_48541776 | 7.24 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
chr12_+_66217911 | 7.09 |
ENST00000403681.2
|
HMGA2
|
high mobility group AT-hook 2 |
chr2_-_38604398 | 7.00 |
ENST00000443098.1
ENST00000449130.1 ENST00000378954.4 ENST00000539122.1 ENST00000419554.2 ENST00000451483.1 ENST00000406122.1 |
ATL2
|
atlastin GTPase 2 |
chr2_-_208030647 | 6.96 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr21_-_28338732 | 6.90 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr3_-_114790179 | 6.80 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr2_+_121103706 | 6.79 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
chr9_-_16870704 | 6.74 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr1_-_225840747 | 6.66 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr19_+_7968728 | 6.57 |
ENST00000397981.3
ENST00000545011.1 ENST00000397983.3 ENST00000397979.3 |
MAP2K7
|
mitogen-activated protein kinase kinase 7 |
chr3_+_187930719 | 6.48 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chrX_-_77150985 | 6.42 |
ENST00000358075.6
|
MAGT1
|
magnesium transporter 1 |
chr3_-_134093395 | 6.27 |
ENST00000249883.5
|
AMOTL2
|
angiomotin like 2 |
chr16_-_85045131 | 6.27 |
ENST00000313732.4
|
ZDHHC7
|
zinc finger, DHHC-type containing 7 |
chr6_-_169654139 | 6.24 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
chr10_+_60272814 | 6.17 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr17_-_62658186 | 5.87 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr2_-_20424844 | 5.85 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr7_+_66386204 | 5.83 |
ENST00000341567.4
ENST00000607045.1 |
TMEM248
|
transmembrane protein 248 |
chr9_-_35732362 | 5.80 |
ENST00000314888.9
ENST00000540444.1 |
TLN1
|
talin 1 |
chr7_-_41742697 | 5.78 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr13_-_41240717 | 5.74 |
ENST00000379561.5
|
FOXO1
|
forkhead box O1 |
chr1_-_108742957 | 5.72 |
ENST00000565488.1
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
chr3_+_193853927 | 5.62 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr20_-_36793774 | 5.54 |
ENST00000361475.2
|
TGM2
|
transglutaminase 2 |
chr17_-_41174424 | 5.51 |
ENST00000355653.3
|
VAT1
|
vesicle amine transport 1 |
chr12_+_69004619 | 5.40 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
chr4_+_87856129 | 5.37 |
ENST00000395146.4
ENST00000507468.1 |
AFF1
|
AF4/FMR2 family, member 1 |
chr3_+_61547585 | 5.32 |
ENST00000295874.10
ENST00000474889.1 |
PTPRG
|
protein tyrosine phosphatase, receptor type, G |
chr5_-_180242534 | 5.30 |
ENST00000333055.3
ENST00000513431.1 |
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr15_-_42264702 | 5.26 |
ENST00000220325.4
|
EHD4
|
EH-domain containing 4 |
chr16_+_68771128 | 5.24 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr3_+_154797428 | 5.17 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
chr1_+_100111479 | 5.15 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
chr21_+_35445827 | 5.04 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr2_+_74425689 | 5.01 |
ENST00000394053.2
ENST00000409804.1 ENST00000264090.4 ENST00000394050.3 ENST00000409601.1 |
MTHFD2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
chr1_+_99127265 | 4.96 |
ENST00000306121.3
|
SNX7
|
sorting nexin 7 |
chr15_-_75744014 | 4.93 |
ENST00000394947.3
ENST00000565264.1 |
SIN3A
|
SIN3 transcription regulator family member A |
chr13_+_113951532 | 4.92 |
ENST00000332556.4
|
LAMP1
|
lysosomal-associated membrane protein 1 |
chrX_-_83442915 | 4.82 |
ENST00000262752.2
ENST00000543399.1 |
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
chr12_-_14721283 | 4.81 |
ENST00000240617.5
|
PLBD1
|
phospholipase B domain containing 1 |
chr2_+_46926048 | 4.79 |
ENST00000306503.5
|
SOCS5
|
suppressor of cytokine signaling 5 |
chrX_+_49687216 | 4.78 |
ENST00000376088.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr8_-_99837856 | 4.78 |
ENST00000518165.1
ENST00000419617.2 |
STK3
|
serine/threonine kinase 3 |
chr16_+_69221028 | 4.75 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr13_+_96329381 | 4.72 |
ENST00000602402.1
ENST00000376795.6 |
DNAJC3
|
DnaJ (Hsp40) homolog, subfamily C, member 3 |
chrX_+_16737718 | 4.71 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
chr10_-_62704005 | 4.71 |
ENST00000337910.5
|
RHOBTB1
|
Rho-related BTB domain containing 1 |
chr3_-_46037299 | 4.54 |
ENST00000296137.2
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
chr5_-_148930960 | 4.46 |
ENST00000261798.5
ENST00000377843.2 |
CSNK1A1
|
casein kinase 1, alpha 1 |
chr19_+_39616410 | 4.40 |
ENST00000602004.1
ENST00000599470.1 ENST00000321944.4 ENST00000593480.1 ENST00000358301.3 ENST00000593690.1 ENST00000599386.1 |
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4 |
chrX_-_131352152 | 4.38 |
ENST00000342983.2
|
RAP2C
|
RAP2C, member of RAS oncogene family |
chr8_-_134309335 | 4.35 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
chr3_+_44626446 | 4.34 |
ENST00000441021.1
ENST00000322734.2 |
ZNF660
|
zinc finger protein 660 |
chr2_-_69614373 | 4.31 |
ENST00000361060.5
ENST00000357308.4 |
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1 |
chr11_+_101981169 | 4.31 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
chr8_+_22462145 | 4.28 |
ENST00000308511.4
ENST00000523801.1 ENST00000521301.1 |
CCAR2
|
cell cycle and apoptosis regulator 2 |
chr1_+_155099927 | 4.27 |
ENST00000368407.3
|
EFNA1
|
ephrin-A1 |
chrX_+_23352133 | 4.21 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
chr15_+_42787452 | 4.18 |
ENST00000249647.3
|
SNAP23
|
synaptosomal-associated protein, 23kDa |
chr7_-_95225768 | 4.14 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
chr5_+_162864575 | 4.12 |
ENST00000512163.1
ENST00000393929.1 ENST00000340828.2 ENST00000511683.2 ENST00000510097.1 ENST00000511490.2 ENST00000510664.1 |
CCNG1
|
cyclin G1 |
chrX_-_153718953 | 4.09 |
ENST00000369649.4
ENST00000393586.1 |
SLC10A3
|
solute carrier family 10, member 3 |
chr7_-_137686791 | 4.07 |
ENST00000452463.1
ENST00000330387.6 ENST00000456390.1 |
CREB3L2
|
cAMP responsive element binding protein 3-like 2 |
chr6_+_108881012 | 4.07 |
ENST00000343882.6
|
FOXO3
|
forkhead box O3 |
chr14_+_50359773 | 4.05 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr1_-_94374946 | 4.01 |
ENST00000370238.3
|
GCLM
|
glutamate-cysteine ligase, modifier subunit |
chr9_+_137218362 | 4.00 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
chr1_+_224544552 | 3.96 |
ENST00000465271.1
ENST00000366858.3 |
CNIH4
|
cornichon family AMPA receptor auxiliary protein 4 |
chrX_-_46618490 | 3.91 |
ENST00000328306.4
|
SLC9A7
|
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 |
chr5_-_32174369 | 3.89 |
ENST00000265070.6
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein) |
chr3_+_29322803 | 3.87 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr7_-_27224795 | 3.84 |
ENST00000006015.3
|
HOXA11
|
homeobox A11 |
chr8_-_89339705 | 3.83 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
chr5_-_160973649 | 3.81 |
ENST00000393959.1
ENST00000517547.1 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chr1_+_93811438 | 3.75 |
ENST00000370272.4
ENST00000370267.1 |
DR1
|
down-regulator of transcription 1, TBP-binding (negative cofactor 2) |
chr1_-_108507631 | 3.73 |
ENST00000527011.1
ENST00000370056.4 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr7_-_23510086 | 3.72 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr17_-_1395954 | 3.72 |
ENST00000359786.5
|
MYO1C
|
myosin IC |
chr3_-_179754706 | 3.68 |
ENST00000465751.1
ENST00000467460.1 |
PEX5L
|
peroxisomal biogenesis factor 5-like |
chr13_-_77460525 | 3.68 |
ENST00000377474.2
ENST00000317765.2 |
KCTD12
|
potassium channel tetramerization domain containing 12 |
chr5_+_172410757 | 3.66 |
ENST00000519374.1
ENST00000519911.1 ENST00000265093.4 ENST00000517669.1 |
ATP6V0E1
|
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
chr19_-_14629224 | 3.65 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr11_+_60681346 | 3.65 |
ENST00000227525.3
|
TMEM109
|
transmembrane protein 109 |
chr7_-_129592700 | 3.63 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
chrX_+_109246285 | 3.60 |
ENST00000372073.1
ENST00000372068.2 ENST00000288381.4 |
TMEM164
|
transmembrane protein 164 |
chr18_-_500692 | 3.59 |
ENST00000400256.3
|
COLEC12
|
collectin sub-family member 12 |
chr22_+_38302285 | 3.58 |
ENST00000215957.6
|
MICALL1
|
MICAL-like 1 |
chr8_+_37654424 | 3.51 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
chr19_-_15560730 | 3.49 |
ENST00000389282.4
ENST00000263381.7 |
WIZ
|
widely interspaced zinc finger motifs |
chr1_+_193091080 | 3.49 |
ENST00000367435.3
|
CDC73
|
cell division cycle 73 |
chr4_+_57774042 | 3.49 |
ENST00000309042.7
|
REST
|
RE1-silencing transcription factor |
chr9_-_38069208 | 3.46 |
ENST00000377707.3
ENST00000377700.4 |
SHB
|
Src homology 2 domain containing adaptor protein B |
chr10_-_15210666 | 3.45 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
chr2_-_26101374 | 3.41 |
ENST00000435504.4
|
ASXL2
|
additional sex combs like 2 (Drosophila) |
chr1_+_206858232 | 3.41 |
ENST00000294981.4
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr1_+_7831323 | 3.40 |
ENST00000054666.6
|
VAMP3
|
vesicle-associated membrane protein 3 |
chr6_+_114178512 | 3.38 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr11_-_106889250 | 3.37 |
ENST00000526355.2
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2 |
chr8_-_28243934 | 3.34 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
chr13_-_40177261 | 3.32 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
chr12_+_56521840 | 3.30 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr3_+_141106643 | 3.25 |
ENST00000514251.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr16_+_58059470 | 3.24 |
ENST00000219271.3
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted) |
chr5_+_170814803 | 3.23 |
ENST00000521672.1
ENST00000351986.6 ENST00000393820.2 ENST00000523622.1 |
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
chr3_+_47324424 | 3.20 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
chr10_-_124768300 | 3.20 |
ENST00000368886.5
|
IKZF5
|
IKAROS family zinc finger 5 (Pegasus) |
chr1_-_52831796 | 3.20 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
chr19_-_8070474 | 3.18 |
ENST00000407627.2
ENST00000593807.1 |
ELAVL1
|
ELAV like RNA binding protein 1 |
chr14_+_103058948 | 3.17 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr7_-_98741642 | 3.17 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
chr20_+_42086525 | 3.16 |
ENST00000244020.3
|
SRSF6
|
serine/arginine-rich splicing factor 6 |
chr13_-_36920420 | 3.13 |
ENST00000438666.2
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr3_-_98620500 | 3.12 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr12_-_102874416 | 3.10 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr17_+_21187976 | 3.09 |
ENST00000342679.4
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr2_+_32502952 | 3.08 |
ENST00000238831.4
|
YIPF4
|
Yip1 domain family, member 4 |
chr2_+_64681219 | 3.07 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
chr10_-_121632266 | 3.07 |
ENST00000360003.3
ENST00000369077.3 |
MCMBP
|
minichromosome maintenance complex binding protein |
chr16_+_30710462 | 3.03 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
chr1_+_179262905 | 3.02 |
ENST00000539888.1
ENST00000540564.1 ENST00000535686.1 ENST00000367619.3 |
SOAT1
|
sterol O-acyltransferase 1 |
chr19_+_1752372 | 2.99 |
ENST00000382349.4
|
ONECUT3
|
one cut homeobox 3 |
chr1_+_113161778 | 2.99 |
ENST00000263168.3
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1 |
chr5_-_77590480 | 2.96 |
ENST00000519295.1
ENST00000255194.6 |
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit |
chr3_-_72496035 | 2.96 |
ENST00000477973.2
|
RYBP
|
RING1 and YY1 binding protein |
chr1_+_26737253 | 2.96 |
ENST00000326279.6
|
LIN28A
|
lin-28 homolog A (C. elegans) |
chr9_-_14314066 | 2.90 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr11_+_69924397 | 2.89 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr2_+_119981384 | 2.88 |
ENST00000393108.2
ENST00000354888.5 ENST00000450943.2 ENST00000393110.2 ENST00000393106.2 ENST00000409811.1 ENST00000393107.2 |
STEAP3
|
STEAP family member 3, metalloreductase |
chr19_+_3359561 | 2.86 |
ENST00000589123.1
ENST00000346156.5 ENST00000395111.3 ENST00000586919.1 |
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor) |
chr7_-_139876812 | 2.86 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr10_+_69644404 | 2.85 |
ENST00000212015.6
|
SIRT1
|
sirtuin 1 |
chr16_-_79634595 | 2.82 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr15_-_56209306 | 2.80 |
ENST00000506154.1
ENST00000338963.2 ENST00000508342.1 |
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr19_+_16222439 | 2.79 |
ENST00000300935.3
|
RAB8A
|
RAB8A, member RAS oncogene family |
chrX_-_132549506 | 2.77 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
chr19_+_17448348 | 2.76 |
ENST00000324894.8
ENST00000358792.7 ENST00000600625.1 |
GTPBP3
|
GTP binding protein 3 (mitochondrial) |
chr15_+_91411810 | 2.72 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr4_-_82136114 | 2.70 |
ENST00000395578.1
ENST00000418486.2 |
PRKG2
|
protein kinase, cGMP-dependent, type II |
chr1_+_65613217 | 2.70 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
chr8_-_57123815 | 2.68 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr1_+_87170247 | 2.66 |
ENST00000370558.4
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1 |
chr10_+_119000604 | 2.66 |
ENST00000298472.5
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2 |
chr14_+_70078303 | 2.63 |
ENST00000342745.4
|
KIAA0247
|
KIAA0247 |
chr16_-_4166186 | 2.62 |
ENST00000294016.3
|
ADCY9
|
adenylate cyclase 9 |
chr11_-_8680383 | 2.62 |
ENST00000299550.6
|
TRIM66
|
tripartite motif containing 66 |
chr11_-_10590238 | 2.61 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr5_-_131132614 | 2.60 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr2_-_166651191 | 2.54 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr1_-_109940550 | 2.54 |
ENST00000256637.6
|
SORT1
|
sortilin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 22.6 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
4.2 | 12.6 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
3.8 | 11.5 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
3.6 | 17.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
3.6 | 10.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
3.4 | 10.1 | GO:0060437 | lung growth(GO:0060437) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
3.1 | 12.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.9 | 8.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
2.4 | 7.1 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
2.1 | 10.3 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
1.9 | 5.8 | GO:0048627 | myoblast development(GO:0048627) |
1.9 | 5.6 | GO:0021558 | midbrain-hindbrain boundary morphogenesis(GO:0021555) trochlear nerve development(GO:0021558) |
1.8 | 5.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.8 | 12.5 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.7 | 20.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.7 | 10.5 | GO:0070417 | cellular response to cold(GO:0070417) |
1.7 | 22.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.7 | 6.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.6 | 4.9 | GO:0051595 | response to methylglyoxal(GO:0051595) |
1.5 | 7.7 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.5 | 16.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.4 | 2.8 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
1.4 | 14.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.4 | 29.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.4 | 4.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
1.3 | 4.0 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
1.3 | 5.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
1.3 | 5.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.3 | 10.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.3 | 6.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 4.9 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
1.2 | 4.8 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
1.2 | 10.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.2 | 9.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.1 | 3.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
1.1 | 5.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.1 | 4.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 4.3 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 26.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.1 | 3.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.0 | 5.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.0 | 4.0 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
1.0 | 6.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.0 | 3.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
1.0 | 3.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
1.0 | 4.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.0 | 14.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.9 | 2.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.9 | 2.7 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.9 | 5.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.9 | 8.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 3.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.9 | 7.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 2.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.8 | 2.4 | GO:0060748 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 19.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 4.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.8 | 7.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 3.1 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.8 | 2.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 11.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.8 | 3.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.7 | 7.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.7 | 10.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 2.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 5.7 | GO:0015866 | ADP transport(GO:0015866) |
0.7 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.7 | 5.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.7 | 2.1 | GO:0035624 | receptor transactivation(GO:0035624) |
0.7 | 2.1 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.7 | 7.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 4.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.7 | 2.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.7 | 8.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.7 | 5.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 2.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.6 | 3.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 3.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 0.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.6 | 3.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 2.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.6 | 2.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.6 | 2.9 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.6 | 0.6 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.6 | 2.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.6 | 1.7 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.5 | 9.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 3.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.5 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 2.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 | 17.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.5 | 5.2 | GO:0015791 | polyol transport(GO:0015791) |
0.5 | 1.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 2.0 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 3.5 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.5 | 8.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 7.0 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.5 | 1.0 | GO:0043416 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.5 | 2.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 7.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 17.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 1.5 | GO:2000364 | negative regulation of glucagon secretion(GO:0070093) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.5 | 2.5 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.5 | 2.4 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.5 | 1.0 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.5 | 1.4 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.5 | 1.9 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.5 | 11.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.5 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 8.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.5 | 1.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 2.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 2.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 2.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 2.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 2.2 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.4 | 3.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.3 | GO:0033206 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) |
0.4 | 2.9 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.4 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 3.2 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.4 | 3.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.4 | 3.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 1.2 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.4 | 30.3 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.4 | 8.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 3.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 1.5 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.4 | 1.1 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.4 | 5.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 12.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.4 | 5.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 3.5 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.3 | 1.4 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.3 | 3.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 1.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.3 | 1.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 3.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.3 | 1.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 3.9 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 4.2 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.2 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.3 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 2.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 4.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.9 | GO:0070781 | response to biotin(GO:0070781) |
0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 9.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 5.0 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 0.8 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.3 | 1.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.3 | 1.0 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 4.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 2.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 4.8 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 3.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 1.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.8 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.2 | 0.6 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) histone H3-K27 demethylation(GO:0071557) |
0.2 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.2 | 1.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 19.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 1.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 28.1 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.2 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.8 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 12.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 3.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 2.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 2.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 1.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 2.8 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.2 | 5.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 5.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.7 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.2 | 6.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 3.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 1.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 2.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 2.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.9 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 1.9 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 1.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 1.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 8.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 6.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 4.7 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.8 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 3.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.9 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 1.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 3.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 6.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 3.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 1.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 2.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 1.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 2.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 4.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 3.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 3.8 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
0.1 | 6.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 0.7 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 1.6 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 2.6 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.1 | 1.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 2.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 2.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 3.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 1.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 12.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 2.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 1.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.1 | 1.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 2.3 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 4.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 4.8 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 1.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 2.4 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.9 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.1 | 4.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 8.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 3.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 2.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 2.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 1.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 3.0 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 1.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.3 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 1.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 1.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.2 | GO:0043488 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
0.0 | 4.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 7.8 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 1.6 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 1.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.8 | GO:0032259 | methylation(GO:0032259) |
0.0 | 1.8 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 1.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 6.3 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 1.0 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.3 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 19.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
3.2 | 29.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
3.2 | 31.7 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
2.1 | 12.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.9 | 5.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.8 | 8.8 | GO:0097513 | myosin II filament(GO:0097513) |
1.4 | 4.3 | GO:0044609 | DBIRD complex(GO:0044609) |
1.4 | 30.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.4 | 12.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.0 | 5.2 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
1.0 | 11.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 4.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.9 | 10.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 3.7 | GO:0045160 | myosin I complex(GO:0045160) |
0.9 | 4.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.8 | 7.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 5.2 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 3.4 | GO:0044216 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.7 | 2.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 10.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.6 | 3.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.6 | 7.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 4.9 | GO:0032010 | phagolysosome(GO:0032010) alveolar lamellar body(GO:0097208) |
0.6 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 2.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.5 | 6.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 2.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 7.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 5.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 1.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.5 | 2.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.0 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 43.5 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 1.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 2.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 3.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 24.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.3 | 4.9 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 34.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 3.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 3.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 6.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 4.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 3.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 65.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 3.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.2 | 3.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 4.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 3.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.6 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.2 | 1.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 17.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 11.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 7.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 10.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 4.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 10.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 4.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 4.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 5.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 2.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 3.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 1.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 7.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 2.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 2.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 17.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 13.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 6.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 56.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 13.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 4.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.1 | 2.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 8.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 32.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 3.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 5.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 2.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 4.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 30.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 4.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 17.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.8 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 1.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 3.0 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 1.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 1.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 29.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 2.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 2.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 12.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
4.0 | 28.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
3.8 | 30.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
3.5 | 17.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
3.4 | 10.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
3.3 | 19.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.9 | 11.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
2.8 | 8.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.6 | 13.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
2.4 | 7.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
2.0 | 10.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.0 | 14.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.9 | 5.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.9 | 7.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
1.8 | 12.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.7 | 5.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.5 | 10.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.3 | 5.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.3 | 7.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.2 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 7.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
1.2 | 3.5 | GO:0070984 | SET domain binding(GO:0070984) |
1.1 | 3.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.1 | 11.2 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 4.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.0 | 4.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 21.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.0 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.9 | 2.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 2.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.8 | 2.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.8 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 11.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 3.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.7 | 7.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 2.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 2.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.7 | 2.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.7 | 5.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.7 | 2.8 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 5.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 2.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 2.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.6 | 2.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 3.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 6.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 1.9 | GO:0032427 | GBD domain binding(GO:0032427) |
0.6 | 5.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.6 | 8.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 2.4 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 12.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 16.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 3.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 2.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.5 | 2.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.5 | 2.5 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.5 | 33.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 1.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.5 | 2.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.4 | 3.6 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 8.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 15.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 31.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 6.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.4 | 1.2 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 2.4 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.4 | 1.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 9.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 2.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 4.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.9 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 4.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 9.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 4.0 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 1.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.4 | 1.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 3.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 9.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 7.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.9 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 2.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 4.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 2.4 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 3.0 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 1.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 4.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 8.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 1.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 2.0 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) kainate selective glutamate receptor activity(GO:0015277) G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 0.8 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.3 | 5.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 7.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 2.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 15.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 6.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 32.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 4.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 2.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 1.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 3.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 3.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 8.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 3.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 2.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 3.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 4.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 3.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 28.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 3.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 4.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 9.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 13.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 4.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 4.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.2 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 6.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 7.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 5.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 3.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 3.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 4.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 4.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 22.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 2.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 4.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 3.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 4.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.2 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.9 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 3.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 2.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 2.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 35.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 3.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 2.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 6.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 3.0 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.1 | 3.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 11.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 3.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 5.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 20.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 2.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 4.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 2.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 7.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 10.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 1.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 8.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 44.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 83.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.8 | 16.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 32.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.7 | 10.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 22.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 13.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 27.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 35.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 9.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 12.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 11.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 5.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 6.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 40.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 10.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 8.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 17.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 12.4 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 28.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 10.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 6.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 6.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 6.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 7.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 27.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 5.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 27.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 9.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 3.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 4.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 28.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.0 | 26.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 12.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 36.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.7 | 12.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 7.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.7 | 2.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 18.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 80.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.6 | 18.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.6 | 3.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 10.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 15.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 6.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 11.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 7.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 22.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 14.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 6.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 5.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 26.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 9.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 4.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 7.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 8.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 7.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 16.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 4.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 8.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 18.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 7.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 7.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 3.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 3.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 17.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 6.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 4.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 7.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 6.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 5.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 1.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 5.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 8.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 4.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 2.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 3.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.4 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 0.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |